Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1Z79
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,824
Award facts
- Contract value 100% obligated
- $60,823.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $60,823.85 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections. This firm fixed-price, non-set-aside contract was executed on February 4, 2026, with an ultimate completion date of February 5, 2026. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total contract value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a leading pharmaceutical distributor serving federal healthcare systems including the Defense Health Agency, U.S. Coast Guard, and military treatment facilities worldwide. The company has demonstrated substantial capacity and experience fulfilling federal medical procurement requirements through competitive contracting, supplying a comprehensive range of pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. Dupixent is a prescription biologic medication used in the treatment of allergic and inflammatory conditions, supporting the military healthcare system's capability to provide specialized pharmaceutical therapies to service members and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F1Z79?
SPE2DR26F1Z79 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F1Z79 worth?
The government has obligated $60,824 on SPE2DR26F1Z79.
Is contract SPE2DR26F1Z79 an order under another contract?
Yes. SPE2DR26F1Z79 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Z79 competed?
The extent of competition for SPE2DR26F1Z79 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award